Banno Y, Nakashima T, Kumada T, Ebisawa K, Nonomura Y, Nozawa Y
Department of Biochemistry, University School of Medicine, Japan.
J Biol Chem. 1992 Apr 5;267(10):6488-94.
The effective resolution of human platelet cytosolic phosphoinositide-phospholipase C (PLC) revealed five distinct activity peaks by Q-Sepharose and heparin-Sepharose column chromatographies when assayed using phosphatidylinositol (PI) and phosphatidylinositol 4,5-bisphosphate (PIP2). The results of Western blotting analysis with various antibodies against PLC isozymes showed that peak-Ia (PLC-delta type), peak-Ib (PLC-gamma 1 type), and peak-IIc (PLC-beta type) and two unidentified activity peaks (PLC-IIa and PLC-IIb) were present in human platelet cytosol. A protein with guanosine 5'-3-O-(thio)triphosphate-binding activity was coeluted with the PLC-IIa and was purified to homogeneity. It exhibited 86- and 42-kDa polypeptide bands upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis which were identified as gelsolin and actin by immunostaining, respectively. Large amounts of gelsolin/actin (1:1) complex "gelsolin complex" were detected in the PLC-delta and PLC-gamma 1 fractions. The PLC-gamma 1 and the gelsolin complex were co-immunoprecipitated by the antibody raised against PLC-gamma 1. Furthermore, the partially purified bovine brain PLC-gamma 1 fraction also was found to be associated with the gelsolin complex and the association was released by the addition of 1% sodium cholate. This finding has prompted us to examine effects of the gelsolin complex and the free gelsolin on activities of the above PLC isoforms from platelet cytosol. The gelsolin complex did not affect the PIP2 hydrolyzing activities of all PLC isoforms. In contrast, the purified gelsolin inhibited distinctly PIP2 hydrolyses by PLC-Ia (delta), PLC-Ib (gamma 1), and PLC-IIa (unidentified), whereas the inhibitory effects for PLC-IIb (unidentified) and PLC-IIc (beta) were moderate. The inhibitory effect of gelsolin on PIP2-hydrolysis by PLC-gamma 1 was diminished by a large amount of PIP2 substrate. These results suggested that the inhibition of PLC by gelsolin is due to sequestration of substrate PIP2 by its competitive binding.
利用磷脂酰肌醇(PI)和磷脂酰肌醇4,5 -二磷酸(PIP2)进行检测时,通过Q -琼脂糖凝胶柱色谱和肝素 - 琼脂糖凝胶柱色谱,人血小板胞质磷酸肌醇 - 磷脂酶C(PLC)的有效分离显示出五个不同的活性峰。用针对PLC同工酶的各种抗体进行蛋白质印迹分析的结果表明,人血小板胞质溶胶中存在峰 - Ia(PLC - δ型)、峰 - Ib(PLC - γ1型)、峰 - IIc(PLC - β型)以及两个未鉴定的活性峰(PLC - IIa和PLC - IIb)。一种具有鸟苷5'-3 - O -(硫代)三磷酸结合活性的蛋白质与PLC - IIa共洗脱,并纯化至同质。在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳上,它呈现出86 kDa和42 kDa的多肽条带,分别通过免疫染色鉴定为凝溶胶蛋白和肌动蛋白。在PLC - δ和PLC - γ1组分中检测到大量的凝溶胶蛋白/肌动蛋白(1:1)复合物“凝溶胶蛋白复合物”。抗PLC - γ1产生的抗体可将PLC - γ1和凝溶胶蛋白复合物共免疫沉淀。此外,还发现部分纯化的牛脑PLC - γ1组分也与凝溶胶蛋白复合物相关,并且通过添加1%的胆酸钠可使这种关联解除。这一发现促使我们研究凝溶胶蛋白复合物和游离凝溶胶蛋白对血小板胞质溶胶中上述PLC同工型活性的影响。凝溶胶蛋白复合物不影响所有PLC同工型的PIP2水解活性。相反,纯化的凝溶胶蛋白明显抑制PLC - Ia(δ)、PLC - Ib(γ1)和PLC - IIa(未鉴定)对PIP2的水解,而对PLC - IIb(未鉴定)和PLC - IIc(β)的抑制作用适中。大量的PIP2底物可减弱凝溶胶蛋白对PLC - γ1水解PIP2的抑制作用。这些结果表明,凝溶胶蛋白对PLC的抑制作用是由于其通过竞争性结合隔离了底物PIP2。